Analysts Set Expectations for Abacus Life Q1 Earnings

Abacus Life, Inc. (NASDAQ:ABL) – Analysts at Northland Capmk issued their Q1 2025 EPS estimates for Abacus Life in a note issued to investors on Monday, November 25th. Northland Capmk analyst M. Grondahl anticipates that the company will post earnings per share of $0.15 for the quarter. Northland Capmk currently has a “Strong-Buy” rating on the stock. The consensus estimate for Abacus Life’s current full-year earnings is $0.64 per share. Northland Capmk also issued estimates for Abacus Life’s Q2 2025 earnings at $0.18 EPS, Q3 2025 earnings at $0.21 EPS, Q4 2025 earnings at $0.24 EPS and FY2025 earnings at $0.78 EPS.

A number of other research firms also recently issued reports on ABL. TD Cowen assumed coverage on shares of Abacus Life in a research report on Wednesday, August 7th. They issued a “buy” rating and a $14.00 price target on the stock. B. Riley Financial reissued a “buy” rating and issued a $16.00 target price on shares of Abacus Life in a report on Friday, August 30th. Piper Sandler reaffirmed an “overweight” rating and set a $13.00 target price (up from $12.00) on shares of Abacus Life in a report on Friday, November 8th. Northland Securities began coverage on Abacus Life in a report on Thursday, October 24th. They issued an “outperform” rating and a $13.50 price target on the stock. Finally, B. Riley upped their price objective on Abacus Life from $16.00 to $17.00 and gave the stock a “buy” rating in a research note on Monday. Five investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Abacus Life has a consensus rating of “Buy” and a consensus target price of $14.70.

Abacus Life Stock Performance

Shares of ABL opened at $8.08 on Thursday. The stock has a market capitalization of $603.17 million, a PE ratio of -43.44 and a beta of 0.15. The business’s fifty day moving average price is $9.22 and its 200 day moving average price is $9.75. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.29 and a quick ratio of 1.29. Abacus Life has a 12-month low of $6.56 and a 12-month high of $13.25.

Abacus Life (NASDAQ:ABL) last issued its earnings results on Thursday, November 7th. The company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.14 by $0.06. Abacus Life had a positive return on equity of 12.88% and a negative net margin of 11.65%. The company had revenue of $28.15 million during the quarter, compared to analyst estimates of $26.08 million. During the same quarter last year, the firm earned $0.01 EPS.

Insider Transactions at Abacus Life

In related news, Director Adam Samuel Gusky bought 18,241 shares of the firm’s stock in a transaction that occurred on Friday, November 22nd. The stock was purchased at an average price of $7.54 per share, for a total transaction of $137,537.14. Following the transaction, the director now directly owns 40,959 shares of the company’s stock, valued at approximately $308,830.86. This represents a 80.29 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jay J. Jackson sold 2,031,250 shares of the business’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $8.00, for a total transaction of $16,250,000.00. Following the sale, the chief executive officer now owns 10,562,000 shares in the company, valued at $84,496,000. This trade represents a 16.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 79.20% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Allspring Global Investments Holdings LLC acquired a new stake in Abacus Life in the second quarter worth approximately $9,909,000. Principal Financial Group Inc. raised its stake in shares of Abacus Life by 7.9% in the 3rd quarter. Principal Financial Group Inc. now owns 1,011,143 shares of the company’s stock worth $10,233,000 after buying an additional 74,172 shares in the last quarter. Point72 Asset Management L.P. bought a new stake in shares of Abacus Life in the 2nd quarter worth $5,190,000. Curi RMB Capital LLC lifted its holdings in shares of Abacus Life by 2.4% in the third quarter. Curi RMB Capital LLC now owns 550,000 shares of the company’s stock valued at $5,566,000 after buying an additional 12,765 shares during the period. Finally, Mendon Capital Advisors Corp acquired a new position in Abacus Life during the second quarter worth about $4,974,000.

Abacus Life Company Profile

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.